Telix Pharmaceuticals Limited American Depositary Receipt logo

Telix Pharmaceuticals Limited American Depositary Receipt (TLX)

Market Closed
27 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
9. 98
-0.24
-2.3483%
$
3.5B Market Cap
- P/E Ratio
- Div Yield
106,243 Volume
- Eps
$ 10.22
Previous Close
Add Transaction
Day Range
9.9 10.32
Year Range
6.28 14.27
Want to track TLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Telix Pharmaceuticals Limited American Depositary Receipt Investors

Name Quantity Cost Value Profit ($) Gain (%)
YA
Yinka Akinsola Blue Trust Inc.
742 $5,557.58 $7,798.42 $2,240.84 40.32%
PF
Phillip Fitzsimmons Hennion & Walsh Asset Management Inc.
150,138 $1.43M $1.58M $145,633.86 10.17%
Brian Baylis
Brian Baylis Bell Investment Advisors Inc.
70 $669.9 $735.7 $65.8 9.82%
Parth Karia
Parth Karia Capricorn Fund Managers Ltd.
36,100 $344,394 $368,942 $24,548 7.13%
Michael Byun
Michael Byun SageView Advisory Group LLC
2 $15 $21.02 $6.02 40.13%
Arpan Shah
Arpan Shah XY Capital Ltd.
12,552 $120,123 $131,921.52 $11,798.52 9.82%
John Shanley
John Shanley Aspect Partners, LLC
401 $3,104.33 $4,214.51 $1,110.18 35.76%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
14 $133.7 $147.14 $13.44 10.05%
SAM
Smartleaf Asset Management LLC Smartleaf Asset Management LLC
37 $286.75 $388.87 $102.12 35.61%
Pascal Bechtold
Pascal Bechtold Raiffeisen Bank International AG
130,000 $1.24M $1.35M $110,500 8.88%